aTyr Pharma, Inc.
NASDAQ:LIFE
Overview | Financials
Company Name | aTyr Pharma, Inc. |
Symbol | LIFE |
Currency | USD |
Price | 1.9 |
Market Cap | 131,120,702 |
Dividend Yield | 0% |
52-week-range | 1.08 - 2.45 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Sanjay S. Shukla M.D., M.S. |
Website | https://www.atyrpharma.com |
An error occurred while fetching data.
About aTyr Pharma, Inc.
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD